Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Dr. Agarwal’s Health Care Ltd. ( (IN:AGARWALEYE) ).
Dr. Agarwal’s Health Care Limited has granted 444,500 stock options under its Employees Stock Option Scheme 2022 to eligible employees of the company and its subsidiaries, following approval by the Nomination and Remuneration Committee at its 3 February 2026 meeting. The options, which correspond to 444,500 equity shares of ₹1 each, will be priced based on fair market value at the grant date with the possibility of up to a 20% discount, subject to a floor at par value, and will vest in four equal annual tranches over four years, reflecting the company’s effort to strengthen employee alignment and retention in line with SEBI’s share-based benefit regulations.
More about Dr. Agarwal’s Health Care Ltd.
Dr. Agarwal’s Health Care Limited operates in the healthcare industry, focusing on eye-care services through a network of clinics and hospitals, and serves patients in India and potentially other markets through its subsidiaries. The company’s operations center on ophthalmology-related treatments and services, positioning it within the specialized healthcare and eye-care segment.
Average Trading Volume: 20,093
Technical Sentiment Signal: Strong Sell
Current Market Cap: 137.9B INR
Learn more about AGARWALEYE stock on TipRanks’ Stock Analysis page.